The number of cancer survivors has increased in recent years due to advances in diagnoses and treatment. CLARIFY PROJECT
It is estimated that more than 50% of adult patients diagnosed with cancer live at least 5 years in the US and Europe. CLARIFY PROJECT
Ensuring post- treatment quality of life of survivors remains a challenge CLARIFY PROJECT
"Having cancer is hard. Finding help shouldn´t be"
THE EU-FUNDED CLARIFY PROJECT WILL IDENTIFY THE RISK FACTORS FOR DETERIORATION IN A PATIENT AT THE END OF ONCOLOGICAL TREATMENT
It will collect data about survivors from breast, lung and lymphoma cancer (the most prevalent types) from hospitals in Spain.
Using big data and artificial intelligence techniques, it will integrate all data with relevant publicly available biomedical information, as well as information from wearable devices used after the treatment.
The data will be analysed to predict patient-specific risk of developing secondary effects and toxicities from their cancer treatments.